Scholar Rock Holding (SRRK) Interest Coverage Ratio Growth (1y) (2018 - 2026)
Scholar Rock Holding (SRRK) Interest Coverage Ratio Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | -347.04% |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 1,378.45% |
| 10 | Scholar Rock Holding | 6.33 Bn | 6.33 Bn | - | -14.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.62% |
| Dec 31, 2025 | -240.16% |
| Sep 30, 2025 | 97.03% |
| Jun 30, 2025 | 95.71% |
| Mar 31, 2025 | -11.44% |
| Dec 31, 2024 | 16.39% |
| Sep 30, 2024 | -16.44% |
| Jun 30, 2024 | -29.59% |
| Mar 31, 2024 | -226.14% |
| Dec 31, 2023 | 3.86% |
| Sep 30, 2023 | -10.77% |
| Jun 30, 2023 | 77.45% |
| Mar 31, 2023 | -237.57% |
| Dec 31, 2022 | 49.84% |
| Sep 30, 2022 | -2,210.66% |
| Jun 30, 2022 | -8,814.95% |
| Mar 31, 2022 | -1,235.81% |
| Dec 31, 2021 | -286.16% |
| Sep 30, 2021 | -22.65% |
| Jun 30, 2021 | 39.48% |